Image
Read our key takeaways from the 2022 ASAS-EULAR recommendations for the management of axSpA, presented as part of Dr Sofia Ramiro's workshop at UCB Summit 2023.
Back to top
Prof Diamant Thaçi
Director and Professor at the Institute and Comprehensive Centre for Inflammation Medicine
Professor Diamant Thaçi is Director and Professor at the Institute and Comprehensive Centre for Inflammation Medicine, University of Lübeck, Germany. Professor Thaçi is also Chairman of the Inflammatory Board at the University Hospital Schleswig-Holstein, Lübeck Campus.
He is an active member of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), the International Psoriasis Council (IPC), the International Eczema Council (IEC), and the Skin Inflammation & Psoriasis International Network (SPIN). His research interests cover immunological work in basic research and all stages of clinical drug development, with a focus on chronic inflammatory skin diseases.
0 resources
Video2 minutes watch
axSpA is a complex disease with a significant burden on many aspects of daily life.1,2 Dive into the importance of ASAS40 for your patients with Dr Fabian Proft.
EU-DA-2400666
Video1 minute watch
Watch Prof Robert Landewé discuss the importance of using ASDAS <2.1 as a treatment target for patients with axSpA.
EU-DA-2400662
Article3 minutes read
EU-DA-2400660
Video2 minutes watch
Watch Prof Lars Erik Kristensen and Prof Frank Behrens discuss the role of the IL-17 family of cytokines in SpA pathobiology.
EU-DA-2400654
Video21 minutes watch
Join Prof Dennis McGonagle and Prof Lars Erik Kristensen in unraveling the role of the IL-17 family in the pathogenic inflammation and manifestations of SpA in...
EU-DA-2400657
Video4 minutes watch
Play the animation to accompany Assoc. Prof Philipp Sewerin in deciphering the role of extracellular cytokine targets in SpA pathobiology.
EU-DA-2400656